Clinical trial · Interventional
Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer
Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer to be Involved and Prepared Before, During, and After Start of Radiotherapy Treatment
NCT04394325CI-TRIAL-00099180completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project uses participatory design combined with qualitative and quantitative methods to develop, explore and evaluate the usefulness of a digital information tool to prepare and support patients before, during and after RT as treatment for breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Digital information tool | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group A) Intervention group
- description
- Group A) an intervention group (n=80) who will receive the standard care and information (oral and written) + the digital information tool.
- interventionNames
- Behavioral: Digital information tool
- type
- NO_INTERVENTION
- label
- Group B) Control group
- description
- Group B) a control group (n=80) who will receive standard care and information (oral and written).
Primary outcomes (3)
- measure
- Change in distress
- timeFrame
- Baseline pre intervention
- description
- The National Comprehensive Cancer Network Distress Thermometer is a brief screening tool for cancer patients to assess psychosocial distress
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Adult patients (\>18 years): * diagnosed with breast cancer, stage I-II not receiving adjuvant or neo-adjuvant chemotherapy or anti-Her-2 treatment and * with RT as additional treatment after surgery. * ability to read, write and understand Swedish enough to adhere to the digital information tool and the applied instruments. * that have access to a smartphone. Exclusion Criteria: * not receiving RT have had RT before * diagnosed with dementia
References
Publications (1)
- DERIVEDFristedt S, Smith F, Grynne A, Browall M. Digi-Do: a digital information tool to support patients with breast cancer before, during, and after start of radiotherapy treatment: an RCT study protocol. BMC Med Inform Decis Mak. 2021 Feb 25;21(1):76. doi: 10.1186/s12911-021-01448-3. PMID 33632215